BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer

Apoptosis is fundamental to normal animal development and is the target for many anticancer therapies. Recent studies have explored the consequences of “failed apoptosis” where the apoptotic program is initiated but does not go to completion and does not cause cell death. Nevertheless, this failed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandya, Vrajesh, Githaka, John Maringa, Patel, Namrata, Veldhoen, Richard, Hugh, Judith, Damaraju, Sambasivarao, McMullen, Todd, Mackey, John, Goping, Ing Swie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289861/
https://www.ncbi.nlm.nih.gov/pubmed/32528057
http://dx.doi.org/10.1038/s41419-020-2654-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289861/
https://www.ncbi.nlm.nih.gov/pubmed/32528057
http://dx.doi.org/10.1038/s41419-020-2654-2

Ejemplares similares